HEBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.461000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.093720E-02
Normal-vs-Stage2
3.060000E-01
Normal-vs-Stage3
3.778800E-01
Normal-vs-Stage4
7.232600E-01
Stage1-vs-Stage2
1.854180E-02
Stage1-vs-Stage3
1.061220E-01
Stage1-vs-Stage4
6.983300E-03
Stage2-vs-Stage3
8.534400E-01
Stage2-vs-Stage4
4.391400E-01
Stage3-vs-Stage4
4.446600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.058400E-01
Normal-vs-AfricanAmerican
9.802000E-01
Normal-vs-Asian
1.325750E-01
Caucasian-vs-AfricanAmerican
4.390800E-01
Caucasian-vs-Asian
5.002800E-01
AfricanAmerican-vs-Asian
3.515200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.179800E-01
Normal-vs-Female
2.983400E-01
Male-vs-Female
4.615200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.121900E-02
Normal-vs-Age(41-60Yrs)
5.678200E-01
Normal-vs-Age(61-80Yrs)
1.004410E-01
Normal-vs-Age(81-100Yrs)
5.942800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.638610E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.443400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.130000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.939900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.771600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.056180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.379400E-01
Normal-vs-Daily Drinker
2.754000E-02
Normal-vs-Weekly Drinker
2.675000E-01
Normal-vs-Occasional Drinker
5.234800E-01
Normal-vs-Social Drinker
4.392000E-01
Non Drinker-vs-Daily Drinker
5.551400E-01
Non Drinker-vs-Weekly Drinker
7.183800E-01
Non Drinker-vs-Occasional Drinker
4.459600E-01
Non Drinker-vs-Social Drinker
8.908600E-01
Daily Drinker-vs-Weekly Drinker
2.995200E-01
Daily Drinker-vs-Occasional Drinker
2.287200E-01
Daily Drinker-vs-Social Drinker
8.821800E-01
Weekly Drinker-vs-Occasional Drinker
7.184600E-01
Weekly Drinker-vs-Social Drinker
7.165200E-01
Occasional Drinker-vs-Social Drinker
5.320800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.113400E-01
Normal-vs-Grade 2
1.743770E-01
Normal-vs-Grade 3
2.351400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.236900E-03
Grade 1-vs-Grade 3
9.915700E-03
Grade 1-vs-Grade 4
7.113400E-01
Grade 2-vs-Grade 3
5.388800E-01
Grade 2-vs-Grade 4
1.743770E-01
Grade 3-vs-Grade 4
2.351400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.659360E-01
Normal-vs-NonDiabetic
3.183800E-01
Diabetic-vs-NonDiabetic
5.322200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.751600E-01
Normal-vs-NoPancreatitis
2.266600E-01
Pancreatitis-vs-NoPancreatitis
3.625800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.770050E-01
Normal-vs-N1
2.986600E-01
N0-vs-N1
1.002200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.794200E-01
Normal-vs-TP53-NonMutant
1.101410E-01
TP53-Mutant-vs-TP53-NonMutant
4.204800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
